Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Las Vegas Housing Supply Rises 31% As Demand Stumbles, Pushing Sale Prices Down Slightly

(NASDAQ:RDFN) SEATTLE--(BUSINESS WIRE)-- #housingmarket--The total number of homes for sale in Las Vegas rose 31% year over year in July, the biggest increase of any major U.S. metro area and rough...

What are the near‑term implications for Redfin’s valuation multiples and guidance, considering the pressure on sale prices and potential need for higher marketing spend to clear excess inventory? Is this inventory surge in Las Vegas indicative of a broader softening in the U.S. housing market that could affect Redfin’s performance in other high‑growth metros? How will the 31% YoY increase in Las Vegas inventory and the 8.6% drop in pending sales impact Redfin’s transaction volume and revenue outlook?
Symbol: RDFN
Housing market
19 days ago
Read more businesswire

Esperion’s Bempedoic Acid Receives Level 1a Recommendation in Updated ESC/EAS Guidelines for Management of Dyslipidaemias

(NASDAQ:ESPR) – Bempedoic Acid Receives Strongest Endorsement from ESC/EAS Guidelines Based on Compelling and Practice-Changing Evidence –

How does this endorsement position bempedoic acid against competing lipid‑lowering therapies such as PCSK9 inhibitors and statins in terms of market share and pricing power? What is the expected timeline for commercial rollout and payer coverage of bempedoic acid following the guideline endorsement? How will the ESC/EAS Level 1a recommendation affect Esperion's revenue outlook and stock valuation?
Symbol: ESPR
Guidelines
19 days ago
Read more globenewswire

Rocket Doctor AI Reports First Revenues in Q2, 2025 Following Acquisition

(AIDR) Vancouver, British Columbia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment.com AI Inc.). (the “Company”) (CSE: AIDR; OTC: TREIF; FFA: 939) is pleased to anno...

What is the anticipated impact of the first revenue run‑rate on the stock’s valuation relative to peers in the AI health sector? When will the company provide guidance on future revenue growth and profitability post‑acquisition? How much revenue did Rocket Doctor AI generate in Q2 and how does it compare to the acquisition's contribution expectations?
Symbol: AIDR
Earnings
19 days ago
Read more globenewswire